2010 Kyoto Prize Laureate in Advanced Technology

Shinya Yamanaka

Development of Technology for Generating Induced Pluripotent Stem(iPS)Cells
By introducing just four transcription factor genes into dermal fibroblasts, Dr. Yamanaka succeeded in producing induced pluripotent stem(iPS)cells, which exhibit a pluripotency similar to that of embryonic stem(ES)cells. The iPS cell technology is now expected not only to expand the possibilities of regenerative medicine, but also to make significant contributions to the rapid progress of medical science in general.

Life History

Born in Osaka, Japan, in 1962. Influenced by his father who operated a small factory of producing sewing machine parts, he loved tinkering with machines. He was once scolded by his mother for taking clocks apart and being unable to put them back together.

Encouraged by his father, he decided to become a doctor and entered Kobe University School of Medicine. As he experienced breaking a bone many times during his sports activities, he thought to become an orthopedist. But while examining patients suffering from injury and intractable disease, he recognized the importance of the basic research aimed at discovering the causes of illnesses, and made up his mind to become a medical researcher.

He understood that somatic cells originally evolve from a single fertilized egg, but he believed that if it were possible to create a cell that behaved much like a fertilized egg, as though travelling back in time, then this could be of great use in the treatment of diseases and injuries. On the path toward realizing his dream of putting such a cell to practical use, he undertook research from 1993 at the Gladstone Institute of Cardiovascular Disease in the U.S., from 1999 at Nara Institute of Science and Technology, and from 2004 at Kyoto University. In 2006, he identified four important genes, and using mice, he successfully created pluripotent cells which are able to change into any type of cell. He named these Induced Pluripotent Stem (iPS) Cells. The following year, he succeeded in creating iPS cells from human skin cells.

As Director of Center for iPS Cell Research and Application, which was established at Kyoto University in 2010, he conducts research aimed at developing new drugs and contributing to the field of regenerative medicine.

*The nationality, the tittle and the organization are those when awarded.


受賞年度: 
2010
受賞回: 
26
部門
部門: 
Advanced Technology
分野: 
Biotechnology and Medical Technology
キャッチコピー: 
Development of Technology for Generating Induced Pluripotent Stem(iPS)Cells
国籍: 
Japan
生年: 
1962
肩書: 
Medical Scientist
所属: 
Professor, Kyoto University
顔写真: 
プロフィール: 
By introducing just four transcription factor genes into dermal fibroblasts, Dr. Yamanaka succeeded in producing induced pluripotent stem(iPS)cells, which exhibit a pluripotency similar to that of embryonic stem(ES)cells. The iPS cell technology is now expected not only to expand the possibilities of regenerative medicine, but also to make significant contributions to the rapid progress of medical science in general.
記念講演会PDF: 
コンテンツ1
コンテンツ1 タイトル: 
Life History
掲載/非掲載: 
掲載
NEWをつける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
クラス名: 
lifehistory
コンテンツ1 本文: 
<img src="/sites/default/files/future/laureates/ShinyaYamanaka_01.jpg" class="fig1" />Born in Osaka, Japan, in 1962. Influenced by his father who operated a small factory of producing sewing machine parts, he loved tinkering with machines. He was once scolded by his mother for taking clocks apart and being unable to put them back together. <br /> <br /> Encouraged by his father, he decided to become a doctor and entered Kobe University School of Medicine. As he experienced breaking a bone many times during his sports activities, he thought to become an orthopedist. But while examining patients suffering from injury and intractable disease, he recognized the importance of the basic research aimed at discovering the causes of illnesses, and made up his mind to become a medical researcher. <br /> <br /> He understood that somatic cells originally evolve from a single fertilized egg, but he believed that if it were possible to create a cell that behaved much like a fertilized egg, as though travelling back in time, then this could be of great use in the treatment of diseases and injuries. On the path toward realizing his dream of putting such a cell to practical use, he undertook research from 1993 at the Gladstone Institute of Cardiovascular Disease in the U.S., from 1999 at Nara Institute of Science and Technology, and from 2004 at Kyoto University. In 2006, he identified four important genes, and using mice, he successfully created pluripotent cells which are able to change into any type of cell. He named these Induced Pluripotent Stem (iPS) Cells. The following year, he succeeded in creating iPS cells from human skin cells.<br /> <br /> <img src="/sites/default/files/future/laureates/ShinyaYamanaka_02.jpg" class="fig3" />As Director of Center for iPS Cell Research and Application, which was established at Kyoto University in 2010, he conducts research aimed at developing new drugs and contributing to the field of regenerative medicine.
コンテンツ2
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ3
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ4
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ5
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ6
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ7
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ8
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ9
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない
コンテンツ10
掲載/非掲載: 
非掲載
NEWを付ける: 
NEWをつけない
ページのアクセスの際に最初に見せる: 
ページのアクセスの際に最初に見せない
個別コンテンツ: 
個別コンテンツにしない